Evidence map›Paper›PMID 21478910›Full record

ArticleOncogene2011

OTX1 expression in breast cancer is regulated by p53.

A Terrinoni, I S Pagani, I Zucchi, A M Chiaravalli, V Serra, F Rovera, S Sirchia, G Dionigi, M Miozzo, A Frattini and 8 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. International journal of molecular sciences · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Expression ofJournal of ophthalmology · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Phenotypic Plasticity of Fibroblasts during Mammary Carcinoma Development.International journal of molecular sciences · 2019
    Article
  16. Article
  17. Identification of a 5-Gene Signature Predicting Progression and Prognosis of Clear Cell Renal Cell Carcinoma.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
    Curto, F L [corrected to Curto, F Lo]
  • Erratum issued
5 · Who and what money

Authors and funding

18 authors at 8 institutions in 2 countries.

A TerrinoniBiochemistry Laboratory, IDI-IRCCS, c/o Department of Experimental Medicine and Biochemical Sciences, University of Rome Tor Vergata, Rome, Italy.
I S Pagani
I Zucchi
A M Chiaravalli
V Serra
F Rovera
S Sirchia
G Dionigi
M Miozzo
A Frattini
A Ferrari
C Capella
F Pasquali
F Lo Curto
F L Curto
A Albertini
G Melino
G Porta
University of Insubria · ITInstitute of Biomedical Technologies · ITUniversity of Milan · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITOspedale di Circolo e Fondazione Macchi · ITPoliclinico San Matteo Fondazione · ITUniversity of Leicester · GBUniversity of Rome Tor Vergata · IT

Funding

Medical Research Council MC_U132670600Telethon GGP09133
6 · The paper itself

Abstract

The p53 transcription factor has a critical role in cell stress response and in tumor suppression. Wild-type p53 protein is a growth modulator and its inactivation is a critical event in malignant transformation. It has been recently demonstrated that wild-type p53 has developmental and differentiation functions. Indeed an over-expression of p53 in tumor cells induces asymmetrical division avoiding self-renewal of cancer stem cells (CSCs) and instead promoting their differentiation. In this study, 28 human breast carcinomas have been analyzed for expression of wild-type p53 and of a pool of non-clustered homeobox genes. We demonstrated that orthodenticle homolog 1 gene (OTX1) is transcribed in breast cancer. We established that the p53 protein directly induces OTX1 expression by acting on its promoter. OTX1 has been described as a critical molecule for axon refinement in the developing cerebral cortex of mice, and its activity in breast cancer suggests a synergistic function with p53 in CSC differentiation. Wild-type p53 may regulate cellular differentiation by an alternative pathway controlling OTX1 signaling only in breast cancer cells and not in physiological conditions.

Indexed as

Breast NeoplasmsFemaleGene Expression Regulation, NeoplasticHumansOtx Transcription FactorsTumor Suppressor Protein p53OTX1 protein, humanOtx Transcription FactorsTumor Suppressor Protein p53

Identifiers

PMID21478910
OpenAlexW2020804015

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.